ACC expands PINNACLE registry to include AF patients
The American College of Cardiology (ACC) is expanding its outpatient registry, the PINNACLE Registry, with a new platform focusing on atrial fibrillation and including the next generation of anticoagulants.
The new platform, PINNACLE-AF, will operate within the existing PINNACLE Registry. The PINNACLE Registry, a U.S. cardiovascular outpatient database, is part of the ACC’s National Cardiovascular Data Registry (NCDR), which is a cardiovascular patient data registry for quality improvement in the U.S.
“PINNACLE can provide a means to monitor practice pattern changes over time while we rigorously assess current practice patterns and help providers evaluate and improve adherence to established guidelines and performance measures,” said Jack C. Lewin, MD, CEO of the ACC.
PINNACLE currently has 2.1 million patient records representing valid patient encounters from hundreds of U.S. outpatient practices. Of those patients, more than 100,000 have atrial fibrillation. Participation in the registry is free to all cardiology practices.
Bristol-Myers Squibb and Pfizer, both headquartered in New York City, support this program.
The new platform, PINNACLE-AF, will operate within the existing PINNACLE Registry. The PINNACLE Registry, a U.S. cardiovascular outpatient database, is part of the ACC’s National Cardiovascular Data Registry (NCDR), which is a cardiovascular patient data registry for quality improvement in the U.S.
“PINNACLE can provide a means to monitor practice pattern changes over time while we rigorously assess current practice patterns and help providers evaluate and improve adherence to established guidelines and performance measures,” said Jack C. Lewin, MD, CEO of the ACC.
PINNACLE currently has 2.1 million patient records representing valid patient encounters from hundreds of U.S. outpatient practices. Of those patients, more than 100,000 have atrial fibrillation. Participation in the registry is free to all cardiology practices.
Bristol-Myers Squibb and Pfizer, both headquartered in New York City, support this program.